Violation Tracker Individual Record
Date:February 4, 2010
Offense Group:healthcare-related offenses
Primary Offense:off-label or unapproved promotion of medical products
Ely Lilly agreed to pay $18.5 million in settlement of allegations it misrepresented the safety of the drug Zyprexa and marketed it for unapproved conditions, thus causing fraudulent charges to Medicaid.
Level of Government:state
Action Type:agency action
Agency:Mississippi Attorney General
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:Indiana
Ownership Structure of Parent:publicly traded
Major Industry of Parent:pharmaceuticals
Specific Industry of Parent:pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.